Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
Low
1.45
High
9.75
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aptose Biosciences Inc | APS | Toronto | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.04 | -2.48% | 1.57 | 14:57:08 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.65 | 1.57 | 1.65 | 1.61 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 30 | 6,502 | - | 1.45 - 9.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:37:07 | 100 | $ 1.57 | CAD |
Aptose Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 26.26M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aptose Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.59 | 1.69 | 1.45 | 1.56 | 5,133 | -0.02 | -1.26% |
| 1 Month | 1.70 | 1.73 | 1.45 | 1.63 | 5,637 | -0.13 | -7.65% |
| 3 Months | 2.45 | 2.47 | 1.45 | 1.86 | 10,071 | -0.88 | -35.92% |
| 6 Months | 3.19 | 3.90 | 1.45 | 2.29 | 7,928 | -1.62 | -50.78% |
| 1 Year | 8.70 | 9.75 | 1.45 | 3.36 | 5,781 | -7.13 | -81.95% |
| 3 Years | 96.45 | 104.70 | 1.45 | 29.76 | 24,458 | -94.88 | -98.37% |
| 5 Years | 39.90 | 189.30 | 1.45 | 80.12 | 36,927 | -38.33 | -96.07% |
Aptose Biosciences Description
| Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. |
